For nearly four decades, cancer researchers faced a persistent problem. They knew that a mutation in a gene called KRAS was driving some of the deadliest tumors for pancreatic, lung, and colorectal cancers, but every attempt to build a drug that could block it came up short.
Similar Posts
Strawberry Apple Pie
It’s pie season, people! This strawberry apple pie is a fun twist on a classic apple…
Zeto Receives FDA Clearance for Its User-Friendly EEG Brain Monitoring System – MedCity News
There is a significant unmet need for effective brain monitoring across various healthcare settings — including…
A Foolproof Trick To Remove Waterproof Mascara *Without* Losing Lashes
Summer heat can do a number on our makeup. If you’re one to break a sweat…
How Healthcare Leaders Are Reacting to the Supreme Court Preserving Abortion Pill Access – MedCity News
The U.S. Supreme Court sided with the FDA on Thursday morning, unanimously ruling to uphold access…
GSK Pays CureVac €400M to Pick Up Clinical-Stage mRNA Vaccines for Infectious Diseases – MedCity News
GSK and CureVac forged their relationship during the Covid-19 pandemic, setting out to develop messenger RNA…
Creating Your Dream Garden Wedding: Tips and Tricks for a Memorable Celebration – Rosanna Davison Nutrition
A gorgeous garden space, with lush greenery and tranquil ambiance, can serve as the perfect setting…
